Cite
APA Citation
Maggiolo, F., Gianotti, N., Comi, L., Di Filippo, E., Fumagalli, L., Nozza, S., Galli, L., Valenti, D., Rizzi, M., & Castagna, A. (2020). rilpivirine plus cobicistat-boosted darunavir as a two-drug switch regimen in HIV-infected, virologically suppressed subjects on steady standard three-drug therapy: a randomized, controlled, non-inferiority trial (PROBE 2). Journal of antimicrobial chemotherapy, 75, 1332–1337. http://access.bl.uk/ark:/81055/vdc_100116625093.0x00003b